ARMP earnings: a positive outcome, +13.9%

On May 7, 2024, Armata Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +13.9% in the window around the event. It had already run -34.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.